Purchase Short-Term Access

Review: Androgen deprivation therapy does not increase CV mortality in prostate cancer
Steven E. Canfield, MD; Philipp Dahm, MD, MHSc, FACS

Annals of Internal Medicine 2012;156:JC4-4. doi:10.7326/0003-4819-156-8-201204170-02004

Purchase Online access to this article for 24 hours
Buy Now

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.